{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:39:49Z","timestamp":1788093589891,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.yebeh.2024.109949","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T03:23:45Z","timestamp":1723087425000},"page":"109949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: A retrospective study using the National Database Open Data Japan"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-4370","authenticated-orcid":false,"given":"Hiroyuki","family":"Ura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Sadamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.109949_b0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.0000000000002119","article-title":"Developmental effects of antiepileptic drugs and the need for improved regulations","volume":"86","author":"Meador","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.109949_b0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamaneurol.2019.0447","article-title":"Antiepileptic drug treatment patterns in women of childbearing age with epilepsy","volume":"76","author":"Kim","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2024.109949_b0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","article-title":"Teratogenic effects of antiepileptic drugs","volume":"11","author":"Tomson","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2024.109949_b0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2024.109949_b0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/epi.14010","article-title":"Risk of pharmacokinetic interactions between antiepileptic and other drugs in older persons and factors associated with risk","volume":"59","author":"Faught","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109949_b0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1076029616687849","article-title":"Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants","volume":"24","author":"Clark","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.yebeh.2024.109949_b0035","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s40263-019-00677-5","article-title":"Ischemic and Thrombotic Events Associated with Concomitant Xa-inhibiting Direct Oral Anticoagulants and Antiepileptic Drugs: Analysis of the FDA Adverse Event Reporting System (FAERS)","volume":"33","author":"Perlman","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2024.109949_b0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40263-021-00795-z","article-title":"Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study","volume":"35","author":"Perlman","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2024.109949_b0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","article-title":"P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy","volume":"72","author":"Oberndorfer","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1016\/j.yebeh.2024.109949_b0050","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients","volume":"58","author":"Farhat","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.109949_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.seizure.2012.10.002","article-title":"Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database","volume":"22","author":"Nicholas","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.109949_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106428","article-title":"Impact of enzyme-inducing anti-epilepsy drugs on lipid levels in elderly patients with epilepsy","volume":"166","author":"Okada","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.109949_b0065","first-page":"572","article-title":"Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate","volume":"69","author":"Fex","year":"1995","journal-title":"Possible relation to teratogenicity Arch Toxicol"},{"key":"10.1016\/j.yebeh.2024.109949_b0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1528-1157.1984.tb04158.x","article-title":"Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)","volume":"25","author":"Lindhout","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109949_b0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0041-008X(77)90108-9","article-title":"A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin, and primidone in mice","volume":"40","author":"Sullivan","year":"1977","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.yebeh.2024.109949_b0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.reprotox.2006.03.014","article-title":"Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy","volume":"22","author":"Ornoy","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.yebeh.2024.109949_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.yebeh.2024.109949_b0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WCO.0000000000000659","article-title":"Teratogenicity of antiepileptic drugs","volume":"32","author":"Tomson","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2024.109949_b0095","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2024.109949_b0100","year":"2023","journal-title":"NDB Open Data Japan [in Japanese] [Internet]"},{"key":"10.1016\/j.yebeh.2024.109949_b0105","unstructured":"Ministry of Health, Labour and Welfare. Changes in electric claims data at medical institution based on numbers of claims data [in Japanese] [Internet]. [accessed 6 May 2024]. Available from: https:\/\/www.ssk.or.jp\/tokeijoho\/tokeijoho_rezept\/tokeijoho_rezept_r03.files\/seikyu_0403.pdf\/; 2022."},{"key":"10.1016\/j.yebeh.2024.109949_b0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7883\/yoken.JJID.2021.450","article-title":"The use of topical antibiotics based on the national database of health insurance claims and specific health checkups of Japan (NDB) Open Data in 2017","volume":"75","author":"Nakanishi","year":"2022","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.yebeh.2024.109949_b0115","doi-asserted-by":"crossref","first-page":"12130","DOI":"10.3390\/ijerph191912130","article-title":"Understanding the Actual Use of Anti-HIV Drugs in Japan from 2016 to 2019: Demonstrating Epidemiological Relevance of NDB Open Data Japan for Understanding Japanese Medical Care","volume":"19","author":"Tanaka","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.yebeh.2024.109949_b0120","unstructured":"Ministry of Health, Labour and Welfare. Annual changes in life expectancy [in Japanese] [Internet]. [accessed 6 May 2024]. Available from: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/life\/tdfk20\/dl\/tdfk20-05.pdf\/; 2021."},{"key":"10.1016\/j.yebeh.2024.109949_b0125","first-page":"200","article-title":"Old and new rules for dosage determination in paediatrics","volume":"5","author":"Augsberger","year":"1962","journal-title":"Triangle"},{"key":"10.1016\/j.yebeh.2024.109949_b0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2188\/jea.JE20220316","article-title":"Incidence and prevalence of epilepsy in Japan - A retrospective analysis of insurance claims data of 9,864,278 insured persons","volume":"34","author":"Kurisu","year":"2024","journal-title":"J Epidemiol"},{"key":"10.1016\/j.yebeh.2024.109949_b0135","first-page":"CD011412","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"4","author":"Nevitt","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2024.109949_b0140","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/epi.17235","article-title":"Big data analysis of ASM retention rates and expert ASM algorithm: A comparative study","volume":"63","author":"H\u00e5kansson","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109949_b0145","doi-asserted-by":"crossref","unstructured":"Perucca E, Battino D, Tomson T. Gender issues in antiepileptic drug treatment. Neurobiol Dis 2014;72 Pt B:217\u201323. https:\/\/doi.org\/10.1016\/j.nbd.2014.05.011.","DOI":"10.1016\/j.nbd.2014.05.011"},{"key":"10.1016\/j.yebeh.2024.109949_b0150","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/pds.4749","article-title":"Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database","volume":"28","author":"Ishikawa","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2024.109949_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.seizure.2022.04.007","article-title":"Trends in the prescription of anti-seizure medicines for pregnant women outpatients with epilepsy during 2016\u20132020 in Japan","volume":"98","author":"Kikuchi","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.109949_b0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/adc.2008.144386","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2024.109949_b0165","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40272-015-0147-z","article-title":"Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children\u2019s Hospital in Korea, 2001\u20132012","volume":"17","author":"Cho","year":"2015","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.yebeh.2024.109949_b0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pediatrneurol.2017.05.016","article-title":"Trends in antiepileptic drug use in children and adolescents with epilepsy","volume":"74","author":"Liu","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2024.109949_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106503","article-title":"Prescription patterns of antiepileptic drugs for adult patients with newly diagnosed focal epilepsy from 2006 to 2017 in Japan","volume":"169","author":"Chen","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.109949_b0180","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/epi.17226","article-title":"Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy","volume":"63","author":"Terman","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109949_b0185","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2024.109949_b0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0920-1211(92)90069-6","article-title":"Carbamazepine induced bradycardia - a problem in general or only in susceptible patients? A 24-h long-term electrocardiogram study","volume":"13","author":"Kenneb\u00e4ck","year":"1992","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.109949_b0195","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.109949_b0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2018.03.023","article-title":"Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients","volume":"143","author":"Intravooth","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.109949_b0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40262-013-0067-4","article-title":"Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update","volume":"52","author":"Italiano","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.yebeh.2024.109949_b0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pediatrneurol.2023.03.016","article-title":"Selection and Continuation of Antiseizure Medication in Children With Epilepsy in Sweden From 2007 to 2020","volume":"144","author":"H\u00e5kansson","year":"2023","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2024.109949_b0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/17425255.2012.645535","article-title":"Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects","volume":"8","author":"Jankovic","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.yebeh.2024.109949_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106297","article-title":"Patterns of antiepileptic drug use among elderly patients with epilepsy: 2004\u20132015","volume":"161","author":"Fox","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.109949_b0225","unstructured":"Ministry of Health, Labour and Welfare. Percentage of generic drugs in use by insurer [in Japanese]. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000190726.html\/; 2023 [accessed 6 May 2024]."},{"key":"10.1016\/j.yebeh.2024.109949_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107876","article-title":"Use of antiseizure medications and safety of branded versus generic formulations: A comparative study on Tuscan administrative databases","volume":"117","author":"Giometto","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.109949_b0235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.121.000994","article-title":"Therapeutic basis of generic substitution of antiseizure medications","volume":"381","author":"Elmer","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2024.109949_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107554","article-title":"Widespread skeptic attitudes among people with epilepsy toward generic antiseizure drugs - A Swedish survey study","volume":"114","author":"Olsson","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.109949_b0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1528-1167.2008.01794.x","article-title":"Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study","volume":"50","author":"Faught","year":"2009","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024003305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024003305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T04:15:00Z","timestamp":1726373700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024003305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":49,"alternative-id":["S1525505024003305"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109949","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: A retrospective study using the National Database Open Data Japan","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109949"}}